US Stock MarketDetailed Quotes

OS Therapies (OSTX)

Watchlist
  • 1.470
  • 0.0000.00%
Close Jan 23 16:00 ET
  • 1.460
  • -0.010-0.65%
Post 19:54 ET
51.77MMarket Cap-2.41P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OS Therapies (OSTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
182.25%6.88M
520.51%4.84M
693.28%5M
56.91%6.81M
156.38%2.97M
291.73%2.44M
-48.54%779.8K
-39.87%630.23K
-2.33%4.34M
1.16M
Selling and administrative expenses
154.59%3.12M
510.39%2.34M
1,274.82%3.69M
253.09%3.97M
1,418.42%2.1M
631.76%1.23M
-26.65%383.23K
-8.78%268.42K
-2.42%1.13M
--138.04K
-General and administrative expense
154.59%3.12M
510.39%2.34M
1,274.82%3.69M
253.09%3.97M
1,418.42%2.1M
631.76%1.23M
-26.65%383.23K
-8.78%268.42K
-2.42%1.13M
--138.04K
Research and development costs
210.30%3.76M
530.28%2.5M
261.84%1.31M
-11.75%2.84M
-14.58%870.47K
166.27%1.21M
-60.06%396.57K
-52.00%361.81K
-2.26%3.22M
--1.02M
Operating profit
-182.25%-6.88M
-520.51%-4.84M
-693.28%-5M
-56.91%-6.81M
-156.38%-2.97M
-291.73%-2.44M
48.54%-779.8K
39.87%-630.23K
2.33%-4.34M
-1.16M
Net non-operating interest income expense
100.01%65
100.01%64
100.01%66
40.51%-2.05M
97.54%-7.56K
67.63%-437.84K
21.42%-777.68K
-3.73%-828.76K
-90.72%-3.45M
-307.53K
Non-operating interest income
--65
6,300.00%64
--66
--0
---1
--0
--1
--0
--2
--0
Non-operating interest expense
--0
--0
--0
-40.51%2.05M
-97.54%7.56K
-67.63%437.84K
-21.42%777.68K
3.73%828.76K
90.72%3.45M
--307.53K
Other net income (expense)
302.04K
1.12M
-17.25K
Gain on sale of security
----
--302.04K
--1.12M
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
--1.12M
---17.25K
----
----
----
----
----
----
Income before tax
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-1.46M
Income tax
Net income
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-1.46M
Net income continuous Operations
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
---1.46M
Minority interest income
Net income attributable to the parent company
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-1.46M
Preferred stock dividends
1,502.58%2M
6,210.32%1.97M
0.00%31.25K
0.00%125K
31.25K
Other preferred stock dividends
Net income attributable to common stockholders
-139.27%-6.88M
-191.28%-4.54M
-160.15%-3.88M
-37.51%-10.89M
-231.81%-4.96M
-43.31%-2.88M
38.59%-1.56M
20.66%-1.49M
-24.09%-7.92M
-1.5M
Basic earnings per share
-16.67%-0.21
26.92%-0.19
-148.79%-0.18
-128.96%-0.88
-227.48%-0.2378
46.25%-0.18
38.59%-0.26
22.77%-0.0724
-20.79%-0.3843
-0.0726
Diluted earnings per share
-16.67%-0.21
26.92%-0.19
-148.79%-0.18
-128.96%-0.88
-227.48%-0.2378
46.25%-0.18
38.59%-0.26
22.77%-0.0724
-20.79%-0.3843
-0.0726
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 182.25%6.88M520.51%4.84M693.28%5M56.91%6.81M156.38%2.97M291.73%2.44M-48.54%779.8K-39.87%630.23K-2.33%4.34M1.16M
Selling and administrative expenses 154.59%3.12M510.39%2.34M1,274.82%3.69M253.09%3.97M1,418.42%2.1M631.76%1.23M-26.65%383.23K-8.78%268.42K-2.42%1.13M--138.04K
-General and administrative expense 154.59%3.12M510.39%2.34M1,274.82%3.69M253.09%3.97M1,418.42%2.1M631.76%1.23M-26.65%383.23K-8.78%268.42K-2.42%1.13M--138.04K
Research and development costs 210.30%3.76M530.28%2.5M261.84%1.31M-11.75%2.84M-14.58%870.47K166.27%1.21M-60.06%396.57K-52.00%361.81K-2.26%3.22M--1.02M
Operating profit -182.25%-6.88M-520.51%-4.84M-693.28%-5M-56.91%-6.81M-156.38%-2.97M-291.73%-2.44M48.54%-779.8K39.87%-630.23K2.33%-4.34M-1.16M
Net non-operating interest income expense 100.01%65100.01%64100.01%6640.51%-2.05M97.54%-7.56K67.63%-437.84K21.42%-777.68K-3.73%-828.76K-90.72%-3.45M-307.53K
Non-operating interest income --656,300.00%64--66--0---1--0--1--0--2--0
Non-operating interest expense --0--0--0-40.51%2.05M-97.54%7.56K-67.63%437.84K-21.42%777.68K3.73%828.76K90.72%3.45M--307.53K
Other net income (expense) 302.04K1.12M-17.25K
Gain on sale of security ------302.04K--1.12M----------------------------
Other non- operating income (expenses) ----------1.12M---17.25K------------------------
Income before tax -139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M-1.46M
Income tax
Net income -139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M-1.46M
Net income continuous Operations -139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M---1.46M
Minority interest income
Net income attributable to the parent company -139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M-1.46M
Preferred stock dividends 1,502.58%2M6,210.32%1.97M0.00%31.25K0.00%125K31.25K
Other preferred stock dividends
Net income attributable to common stockholders -139.27%-6.88M-191.28%-4.54M-160.15%-3.88M-37.51%-10.89M-231.81%-4.96M-43.31%-2.88M38.59%-1.56M20.66%-1.49M-24.09%-7.92M-1.5M
Basic earnings per share -16.67%-0.2126.92%-0.19-148.79%-0.18-128.96%-0.88-227.48%-0.237846.25%-0.1838.59%-0.2622.77%-0.0724-20.79%-0.3843-0.0726
Diluted earnings per share -16.67%-0.2126.92%-0.19-148.79%-0.18-128.96%-0.88-227.48%-0.237846.25%-0.1838.59%-0.2622.77%-0.0724-20.79%-0.3843-0.0726
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -